1,015 results on '"Pontisso, Patrizia"'
Search Results
2. SerpinB3 as hepatic marker of post-resective shear stress
3. SUMOylation controls Hu antigen R posttranscriptional activity in liver cancer
4. The protease activated receptor 2 - CCAAT/enhancer-binding protein beta - SerpinB3 axis inhibition as a novel strategy for the treatment of non-alcoholic steatohepatitis
5. SAT-219 Discovering 1-piperidine propionic acid inhibiting effect on protease activated receptor 2 and serpinb3 as a new therapeutic strategy for metabolic dysfunction-associated steatohepatitis
6. Hepatocyte-Specific Deletion of HIF2α Prevents NASH-Related Liver Carcinogenesis by Decreasing Cancer Cell Proliferation
7. SerpinB3: A Multifaceted Player in Health and Disease—Review and Future Perspectives.
8. Inhibition of Protease-Activated Receptor-2 Activation in Parkinson's Disease Using 1-Piperidin Propionic Acid.
9. Serum Vascular Adhesion Protein-1 and Endothelial Dysfunction in Hepatic Cirrhosis: Searching for New Prognostic Markers.
10. SERPINB3 in fibrogenic chronic liver diseases and primary liver cancers
11. SerpinB3/4 Expression Is Associated with Poor Prognosis in Patients with Cholangiocarcinoma
12. Labelled micelles for the delivery of cytotoxic Cu(II) and Ru(III) compounds in the treatment of aggressive orphan cancers: Design and biological in vitro data
13. Le complexe antigène de carcinome à cellules squameuses-IgM (SCCA-IgM) est associé à la pneumopathie interstitielle diffuse dans la sclérodermie systémique
14. Squamous cell carcinoma antigen-IgM (SCCA-IgM) is associated with interstitial lung disease in systemic sclerosis
15. Hyperdynamic circulatory syndrome in a mouse model transgenic for SerpinB3
16. The polymorphic variant of SerpinB3 (SerpinB3‐PD) is associated with faster cirrhosis decompensation
17. Galad Score as a Prognostic Marker for Patients with Hepatocellular Carcinoma
18. 1-Piperidine Propionic Acid as an Allosteric Inhibitor of Protease Activated Receptor-2
19. PreS1 peptide-functionalized gold nanostructures with SERRS tags for efficient liver cancer cell targeting
20. The polymorphic variant of SerpinB3 (SerpinB3‐PD) is associated with faster cirrhosis decompensation.
21. Studies on the Role of Compartmentalized Profiles of Cytokines in the Risk of Hepatocellular Carcinoma
22. Novel Molecular Targets for Immune Surveillance of Hepatocellular Carcinoma
23. SerpinB3 induces dipeptidyl-peptidase IV/CD26 expression and its metabolic effects in hepatocellular carcinoma
24. New molecular targets for functionalized nanosized drug delivery systems in personalized therapy for hepatocellular carcinoma
25. Inhibition of CCAT/enhancer-binding protein beta-serpinB3 axis by 1-piperidin propionic acid: a new targeted therapy for non-alcoholic steatohepatitis
26. SerpinB3 Upregulates Low-Density Lipoprotein Receptor-Related Protein (LRP) Family Members, Leading to Wnt Signaling Activation and Increased Cell Survival and Invasiveness
27. Epitope-Specific Anti-SerpinB3 Antibodies for SerpinB3 Recognition and Biological Activity Inhibition
28. Low-Dose Acetylsalicylic Acid and Mitochondria-Targeted Antioxidant Mitoquinone Attenuate Non-Alcoholic Steatohepatitis in Mice
29. Re-programming pullulan for targeting and controlled release of doxorubicin to the hepatocellular carcinoma cells
30. SERPINB3, Adult-Onset Immunodeficiency, and Generalized Pustular Psoriasis
31. The CCAAT/Enhancer-Binding Protein Beta - SerpinB3 Axis Inhibition as a Novel Strategy for Non-Alcoholic Steatohepatitis Treatment
32. AISF position paper on liver transplantation and pregnancy: Women in Hepatology Group, Italian Association for the Study of the Liver (AISF)
33. Squamous cell carcinoma antigen-IgM is associated with hepatocellular carcinoma in patients with cirrhosis: A prospective study
34. SerpinB3 administration protects liver against ischemia-reperfusion injury
35. Role of SERPINB3 in hepatocellular carcinoma
36. Semisolid Wet Sol–Gel Silica/Hydroxypropyl Methyl Cellulose Formulation for Slow Release of Serpin B3 Promotes Wound Healing In Vivo
37. SerpinB3 as a Pro-Inflammatory Mediator in the Progression of Experimental Non-Alcoholic Fatty Liver Disease
38. MicroRNAs and SerpinB3 in hepatocellular carcinoma
39. Assessment of bone mineral density in patients with cirrhosis treated with third-generation nucleos(t)ide analogues: comparison between tenofovir and entecavir
40. Serpinb3 is overexpressed in the liver in presence of iron overload
41. Over-expression of SERPINB3 in hepatoblastoma: A possible insight into the genesis of this tumour?
42. Oncostatin M is overexpressed in NASH‐related hepatocellular carcinoma and promotes cancer cell invasiveness and angiogenesis
43. Oncostatin M is overexpressed in NASH-related hepatocellular carcinoma and promotes cancer cell invasiveness and angiogenesis
44. Hyaluronated and PEGylated Liposomes as a Potential Drug-Delivery Strategy to Specifically Target Liver Cancer and Inflammatory Cells
45. Letter: Association of polymorphic variant of SerpinB3 and faster cirrhosis decompensation in patients with cirrhosis—More evidence needed. Authors' reply.
46. Overexpression of SERPIN B3 promotes epithelial proliferation and lung fibrosis in mice
47. Combination of squamous cell carcinoma antigen immunocomplex and alpha-fetoprotein in mid- and long-term prediction of hepatocellular carcinoma among cirrhotic patients
48. Hepatitis C Virus Infection and Replication in Patients with Hepatocellular Carcinoma
49. The molecular signature of impaired diabetic wound healing identifies serpinB3 as a healing biomarker
50. Serpins, Immunity and Autoimmunity: Old Molecules, New Functions
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.